Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
AstraZeneca pays $24M to join race for next big KRAS opportunity
Partnering with a Chinese biotech once again, AstraZeneca has secured a spot in the congested KRAS G12D space in exchange for $24 million upfront.
Nick Paul Taylor
Nov 27, 2023 6:15am
AstraZeneca launches company to share digital trial expertise
Nov 20, 2023 8:40am
SpringWorks eyes AstraZeneca's Koselugo market with phase 2 data
Nov 16, 2023 10:59am
Regeneron stays out of ADC deal fray as scientists tinker
Nov 15, 2023 9:11am
AstraZeneca CEO: GLP-1 focus is weight management, not obesity
Nov 10, 2023 12:08pm
AstraZeneca pays $185M to reenter obesity race, drops SCD drug
Nov 9, 2023 5:00am
